J0895 HCPCS code: Injection, deferoxamine mesylate, 500 mg
J0895 is the HCPCS Level II code for injection, deferoxamine mesylate, 500 mg. In 2024 Medicare paid an average of $5.92 per service for J0895 across 8,127 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 212 per day on DME suppliers. Medicare volume fell 18% from 2022 to 2024 (9,962 to 8,127 services). In 2024, 46 suppliers billed Medicare for J0895 (purchases), serving 55 beneficiaries; California, Texas, New York accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1992-01-01 |
| Last action effective | 2001-01-01 |
Who bills J0895 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 46 |
| Referring clinicians | 64 |
| Medicare beneficiaries | 55 |
| States with claims | 17 |
| Share of services in top 3 states (California, Texas, New York) | 34% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 64 | 83 |
| 2023 | 48 | 60 |
| 2024 | 46 | 55 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0895, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 9,962 | 146 | $8.26 | $6.52 |
| 2023 | 7,623 | 138 | $8.34 | $6.55 |
| 2024 | 8,127 | 121 | $7.62 | $5.92 |
States with the most J0895 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 1,580 | $5.92 |
| Texas | 1,478 | $6.06 |
| California | 1,258 | $6.03 |
| Florida | 687 | $6.00 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 212 | Clinical: Data |
| outpatient hospital claims | 12 | Prescribing Information |
| practitioner claims | 12 | Prescribing Information |
What changed for J0895
- 1992-01-01: J0895 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0895?
J0895 is the HCPCS Level II code for injection, deferoxamine mesylate, 500 mg. Short descriptor: "Deferoxamine mesylate inj".
How much does Medicare pay for J0895?
In 2024, the average Medicare payment was $5.92 per service (average allowed $7.62).
Does Medicare cover J0895?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J0895 can be billed per day?
212 on DME suppliers; 12 on outpatient hospital claims; 12 on practitioner claims (NCCI medically unlikely edits).
Related J08 codes
- J0800 — Injection, corticotropin, up to 40 units
- J0801 — Injection, corticotropin (acthar gel), up to 40 units
- J0802 — Injection, corticotropin (ani), up to 40 units
- J0833 — Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0834 — Injection, cosyntropin, 0.25 mg
- J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841 — Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850 — Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870 — Injection, imetelstat, 1 mg
- J0871 — Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872 — Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0895
- Watch J0895 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0895
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.